Interactions between PPAR Gamma and the Canonical Wnt/Beta-Catenin Pathway in Type 2 Diabetes and Colon Cancer
In both colon cancer and type 2 diabetes, metabolic changes induced by upregulation of the Wnt/beta-catenin signaling and downregulation of peroxisome proliferator-activated receptor gamma (PPAR gamma) may help account for the frequent association of these two diseases. In both diseases, PPAR gamma...
Saved in:
| Main Authors: | Yves Lecarpentier, Victor Claes, Alexandre Vallée, Jean-Louis Hébert |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2017-01-01
|
| Series: | PPAR Research |
| Online Access: | http://dx.doi.org/10.1155/2017/5879090 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Genetic dissection of differential signaling threshold requirements for the Wnt/beta-catenin pathway in vivo.
by: Michael Buchert, et al.
Published: (2010-01-01) -
Empagliflozin improves pressure-overload-induced cardiac hypertrophy by inhibiting the canonical Wnt/β-catenin signaling pathway
by: Xun Yuan, et al.
Published: (2024-11-01) -
The Dual Role and Therapeutic Implications of the Wnt/β-Catenin Pathway in Diabetic Kidney Disease
by: Adeerjiang Y, et al.
Published: (2025-05-01) -
Natural Bioactive Compounds Targeting the Wnt/β-Catenin Pathway for the Treatment of Hepatocellular Carcinoma
by: Tian H, et al.
Published: (2025-07-01) -
Modulation of Wnt/Beta-Catenin Pathway by Major Dietary Phytochemicals Against Breast Cancer Development
by: Noah Lieb, et al.
Published: (2025-02-01)